Randomised controlled trial comparing the spinal sensory level achieved, duration of action and safety of generic (Bupivacaine 0.5% with Dextrose-PharmaQ) versus original bupivacaine (Macaine 0.5% with dextrose-Adcock Ingram) in spinal anaesthesia

计划入组 72 人

Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery

计划入组 465 人 · 首次发布于 2019 年 1 月 8 日

Limited-duration Teclistamab

计划入组 75 人 · 首次发布于 2023 年 7 月 6 日

Human papillomavirus tumor antigen vaccine (Vanderbilt University/Ingram Cancer Center)

DEP remdesivir (Starpharma Holdings)

Polyomavirus vaccine (BioE Holdings)

THERACOS HOLDINGS LIMITED

Ireland

HBMI HOLDINGS LIMITED

New Zealand

VIEWBEST HOLDINGS LIMITED

Hong Kong, China

Natco Pharma Q1FY27 Net Profit Slumps 57% as Lenalidomide Revenue Declines

Natco Pharma Q1 Profit Slumps 57% on Lenalidomide Sales Erosion; Plans ₹2,000-Crore QIP for Acquisitions

Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results